NasdaqGS:HOLXMedical Equipment
Assessing Hologic (HOLX) Valuation After A 21% One Year Shareholder Return
Hologic (HOLX) sits in focus after recent share performance that includes a return of about 21% over the past year. This has prompted investors to reassess the women’s health specialist at around US$75 per share.
See our latest analysis for Hologic.
That 21.45% 1 year total shareholder return, compared with a relatively modest 1.52% year to date share price return, suggests earlier momentum has cooled somewhat. The stock is settling around US$75.69 as investors reassess potential risks and...